KTPPF yields 400000.00% · MRK yields 2.81%● Live data
📍 KTPPF pulled ahead of the other in Year 1
Combined, KTPPF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of KTPPF + MRK for your $10,000?
Katipult Technology Corp. operates as a financial technology company. The company offers a cloud-based software infrastructure that allows firms to design, set up, and operate an investment platform, which enables firms to offer debt and real-estate financing; and securities on a prospectus-exempt basis to various types of investors. Its platform automates various components of investor and investment management, including components of financial transactions, investment marketing, and dividend payouts, as well as manages regulatory requirements in various geographic jurisdictions. The company's platform includes modules for various user types, including investors, issuers, administrators, and auditors. It serves customers worldwide. The company was formerly known as Deha Capital Corp. and changed its name to Katipult Technology Corp. in August 2017. Katipult Technology Corp. was founded in 2008 and is headquartered in Calgary, Canada.
Full KTPPF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.